Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
atorvastatin (lipitor) (1 trial)
soy isoflavones (1 trial)
Breast Neoplasms (Phase 2)
Cardiotoxicity (Phase 2)
Heart Diseases (Phase 2)
Trials (2 total)
Trial APIs (2 total)